微载体市场－全球产业规模、份额、趋势、机会及预测（依产品、应用、最终用户、地区及竞争格局划分，2021-2031年）

全球微载体市场预计将从 2025 年的 29.1 亿美元成长到 2031 年的 41.1 亿美元，复合年增长率为 5.92%。

随着这些特化的支撑基质使依赖贴壁生长的细胞能够在悬浮生物反应器中生长，全球微载体市场持续扩张，从而推动了从实验室规模的平板培养向工业生物加工的转变。这一成长主要源于疫苗和再生医学领域对可扩展生产解决方案的迫切需求，在这些领域，大规模生产是商业性成功的关键。根据国际细胞与基因治疗学会（ISCT）的数据，到2024年，全球在研细胞和基因疗法将达到3063种，凸显了维持这一强劲临床发展势头对高密度培养系统的关键需求。

然而，下游加工和细胞回收的技术复杂性为市场推广带来了显着障碍。大型生物反应器中高动态剪切应力会对细胞活力构成威胁，而将细胞从载体上分离且不损伤细胞所需的复杂通讯协定往往会导致产量降低。这些挑战使得标准化、一致且经济高效的生产流程变得困难，从而极大地阻碍因素了其在市场上的广泛应用。

市场驱动因素

细胞和基因治疗临床管线的快速扩张是全球微载体市场的主要驱动力，由此产生了对可扩展培养系统的迫切需求，以促进从研究到商业化的转化。随着罕见疾病和肿瘤治疗方法的进展，传统二维平面培养的局限性日益凸显，因此需要利用微载体实现高密度悬浮培养，以确保批次间的一致性并达到商业化水平的病毒载体滴度。根据再生医学联盟于2024年10月发布的《产业趋势》报告，预计该领域在2024年上半年将吸引109亿美元的投资，而对后期研发的大力资助将直接推动先进生物製程耗材的采购。

此外，对可扩展的细胞疫苗生产的需求不断增长，也促使市场更加依赖微载体技术进行高通量病毒生产。为了维持全球疫苗接种覆盖率，製造商正在加速将一次性生物反应器与微载体结合，以在不扩大设施面积下，最大限度地增加依赖附着的病毒宿主（例如Vero细胞）的表面积。世界卫生组织（WHO）于2024年6月发布的《2023年全球疫苗市场报告》指出，2022年全球疫苗市场（不包括新冠肺炎疫苗）的产量将达到约50亿剂，这表明市场对高效的大规模生产平台的需求持续存在。这种不断增长的需求也在推动产业结构的变革。 CPHI于2024年10月发布的年度报告预测，到2028年，契约製造组织（CMO）将控制全球40%的生物製药产能。这表明，微载体的工业化应用正转向外包。

市场挑战

与下游製程优化和细胞回收相关的技术难题是限制全球微载体市场成长的关键因素。这些挑战直接增加了销货成本，限制了治疗方法的商业性动态，阻碍了市场扩张。大型生物反应器内产生的流体动力剪切应力通常会损伤依赖细胞黏附的细胞，而将这些细胞从微载体上分离所需的复杂通讯协定往往会导致显着的产量损失。因此，製造商面临着高失败率和批次品质差异，阻碍了他们从临床试验阶段过渡到盈利的大规模生产。

收穫阶段的产量损失会削弱整个生物製程的经济可行性，迫使企业维持高价位，从而限制患者获得治疗的机会和市场渗透率。这种瓶颈导致只有极少数治疗方法能够克服生产障碍并取得商业性成功。根据再生医学联盟预测，到2025年，全球75%的细胞和基因疗法收入将来自不到10种上市产品。如此高的营收集中度凸显了庞大的研发管线难以克服生产和规模化生产的障碍，从而抑制了整个微载体市场的成长潜力。

市场趋势

生物可降解微载体的日益普及正在革新收穫阶段，解决了细胞脱落和产量损失等技术瓶颈。透过使用可溶解或降解的基质，製造商可以消除细胞分离通常所需的机械剪切力，从而简化下游加工过程并保持细胞活力。随着主要供应商开发适用于工业工作流程的专用解决方案，这项创新正获得商业性认可。例如，Cultivated X 在 2025 年 10 月报道称，康宁公司已公布一项可食用微载体的专利，该微载体旨在保留在最终产品中，从而无需高成本的分离步骤，并有助于提高生产效率。

同时，为最大限度降低病毒污染风险并满足严格的监管安全标准，市场正经历着向无动物成分和无异种成分材料配方的重大转变。这一转变尤其受到新兴的培养肉产业的推动，该产业需要食品级、无动物成分的支架来确保消费者安全和产品一致性。这一细分市场的蓬勃发展正在推动尖端材料的采购。根据良好食品研究所 (Good Food Institute) 2025 年 4 月发布的报告《行业趋势：培养肉、海鲜和配料》，预计该行业的公司将在 2024 年筹集 1.39 亿美元资金，这凸显了对安全、无动物成分生物加工技术开发和应用的强劲投资。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球微载体市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（消耗品、设备）
  • 依应用领域（疫苗生产、治疗性蛋白质生产、组织工程/再生医学等）
  • 依最终用户（生物製药公司、受託研究机构(CRO)、学术研究机构、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美微载体市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲微载体市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区微载体市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲微载体市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲微载体市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球微载体市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Thermo Fisher Scientific, Inc.
• Eppendorf SE
• Danaher Corporation
• Corning Incorporated
• Beckton, Dickson and Company
• Lonza Group Ltd.
• FUJIFILM Holdings Corporation
• Entegris, Inc

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Microcarriers Market will grow from USD 2.91 Billion in 2025 to USD 4.11 Billion by 2031 at a 5.92% CAGR. The Global Microcarriers Market is expanding as these specialized support matrices enable anchorage-dependent cells to thrive in suspension bioreactors, facilitating the shift from laboratory-scale planar cultures to industrial bioprocessing. This growth is primarily driven by the urgent need for scalable manufacturing solutions in the vaccine and regenerative medicine sectors, where mass production is essential for commercial success. Data from the International Society for Cell & Gene Therapy indicates that in 2024, the global pipeline contained 3,063 cell and gene therapies, highlighting the critical demand for high-density culture systems to sustain this intense clinical momentum.

However, market adoption faces significant hurdles due to the technical complexities involved in downstream processing and cell harvesting. High hydrodynamic shear stress within large bioreactors poses a risk to cell viability, while the intricate protocols required to detach cells from carriers without damage often lead to yield reductions. These challenges complicate the standardization of consistent, cost-effective manufacturing workflows, thereby acting as a substantial restraint on broader market integration.

Market Driver

The rapid expansion of the clinical pipeline for cell and gene therapies serves as the primary catalyst for the Global Microcarriers Market, creating an urgent demand for scalable culture systems that facilitate the transition from research to commercialization. As treatments for rare diseases and oncology advance, the limitations of traditional 2D planar cultures become unsustainable, necessitating the use of high-density suspension cultures enabled by microcarriers to ensure lot-to-lot consistency and achieve commercial viral vector titers. The Alliance for Regenerative Medicine's October 2024 'State of the Industry' update noted that the sector attracted $10.9 billion in investment during the first half of 2024, signaling strong financial backing for late-stage development that directly fuels the procurement of advanced bioprocessing supplies.

Additionally, the escalating demand for scalable cell-based vaccine production reinforces the market's reliance on microcarrier technology for high-throughput viral manufacturing. To maintain global immunization coverage, manufacturers are increasingly integrating single-use bioreactors with microcarriers to maximize the surface area for anchorage-dependent viral hosts, such as Vero cells, without increasing facility footprints. The World Health Organization's '2023 Global Vaccine Market Report' from June 2024 highlighted that the global vaccine market volume, excluding COVID-19 products, was approximately 5 billion doses in 2022, underscoring the sustained need for efficient large-scale platforms. This pressure is also driving industry structural changes; the October 2024 CPHI Annual Report projects that contract manufacturing organizations will control 40% of global biologics capacity by 2028, indicating a shift toward outsourced, industrial-scale microcarrier usage.

Market Challenge

The technical difficulty associated with optimizing downstream processing and cell harvesting represents a significant factor impeding the growth of the Global Microcarriers Market. This challenge hampers market expansion by directly inflating the Cost of Goods Sold (COGS) and limiting the commercial scalability of therapies. Hydrodynamic shear stress generated in large bioreactors often damages anchorage-dependent cells, while the complex protocols required to detach these cells from microcarriers frequently lead to substantial yield losses. Consequently, manufacturers face high failure rates and inconsistent batch quality, which prevents the successful transition from clinical trials to profitable, mass-scale production.

When yield losses occur during the harvesting phase, the economic viability of the entire bioprocess is compromised, forcing companies to maintain high price points that restrict patient access and market adoption. This bottleneck creates an environment where only a small fraction of therapies can successfully navigate manufacturing hurdles to achieve commercial success. According to the Alliance for Regenerative Medicine, in 2025, 75% of global revenue within the cell and gene therapy sector was generated by fewer than ten commercial products. This high concentration of revenue highlights the inability of the broader pipeline to overcome manufacturing and scaling barriers, thereby stalling the overall growth potential of the microcarriers market.

Market Trends

The increasing adoption of biodegradable microcarriers is revolutionizing the harvesting phase by addressing technical bottlenecks related to cell detachment and yield loss. By employing matrices that dissolve or degrade, manufacturers can eliminate the mechanical shear forces typically required to separate cells, thereby streamlining downstream processing and preserving cell viability. This innovation is gaining commercial traction as major suppliers develop specialized solutions for industrial workflows; for instance, Cultivated X reported in October 2025 that Corning Inc. published a patent for edible microcarriers designed to remain in the final product, removing the need for costly separation steps and facilitating efficient production cycles.

Simultaneously, a significant shift toward animal-component-free and xenogeneic-free material formulations is reshaping the market, driven by the imperative to minimize viral contamination risks and meet stringent regulatory safety standards. This transition is particularly accelerated by the emerging cultivated meat sector, which requires food-grade, non-animal scaffolds to ensure consumer safety and product consistency. The financial vitality of this niche is fueling the procurement of these advanced materials; the Good Food Institute's April 2025 report, 'State of the Industry: Cultivated meat, seafood, and ingredients,' noted that companies in this sector raised $139 million in 2024, highlighting the robust investment supporting the development and adoption of safe, animal-free bioprocessing technologies.

Key Market Players

• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Thermo Fisher Scientific, Inc.
• Eppendorf SE
• Danaher Corporation
• Corning Incorporated
• Beckton, Dickson and Company
• Lonza Group Ltd.
• FUJIFILM Holdings Corporation
• Entegris, Inc

Report Scope

In this report, the Global Microcarriers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microcarriers Market, By Product

• Consumables
• Equipment

Microcarriers Market, By Application

• Vaccine Production
• Therapeutic Protein Production
• Tissue Engineering and Regenerative
• Others

Microcarriers Market, By End-User

• Biopharmaceutical Companies
• Contract Research Organizations
• Academic and Research Institutes
• Others

Microcarriers Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microcarriers Market.

Available Customizations:

Global Microcarriers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microcarriers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables, Equipment)
  • 5.2.2. By Application (Vaccine Production, Therapeutic Protein Production, Tissue Engineering and Regenerative, Others)
  • 5.2.3. By End-User (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Microcarriers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Microcarriers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Microcarriers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Microcarriers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-User

7. Europe Microcarriers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Microcarriers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-User
  • 7.3.2. France Microcarriers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-User
  • 7.3.3. United Kingdom Microcarriers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Microcarriers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Microcarriers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-User

8. Asia Pacific Microcarriers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Microcarriers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Microcarriers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Microcarriers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Microcarriers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Microcarriers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-User

9. Middle East & Africa Microcarriers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Microcarriers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-User
  • 9.3.2. UAE Microcarriers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-User
  • 9.3.3. South Africa Microcarriers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-User

10. South America Microcarriers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Microcarriers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-User
  • 10.3.2. Colombia Microcarriers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-User
  • 10.3.3. Argentina Microcarriers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Microcarriers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bio-Rad Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sartorius AG
• 15.3. Thermo Fisher Scientific, Inc.
• 15.4. Eppendorf SE
• 15.5. Danaher Corporation
• 15.6. Corning Incorporated
• 15.7. Beckton, Dickson and Company
• 15.8. Lonza Group Ltd.
• 15.9. FUJIFILM Holdings Corporation
• 15.10. Entegris, Inc

16. Strategic Recommendations

17. About Us & Disclaimer